Steve Smyth

Business Unit Director, Multiple Myeloma @Johnson & Johnson Innovative Medicine

Barrie, ON, CA
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2023 — Present

Business Unit Director, Multiple Myeloma @Johnson & Johnson Innovative Medicine

View department →

CA

Responsible for sales and marketing strategy and execution for the entire Multiple Myeloma portfolio at Johnson and Johnson Canada- Achieved global leadership for DARZALEX FL TIE share at over 90% and world leading revenue growth at over 36%- launched first bispscific in Canada for MM- launching first CAR-T for MM in Canada- co-chair for NA Pharm Culture Steering Committee

EDUCATION

1987 — 1991

University of Guelph

BSc, Human Biology/Physiology

1997 — 2000

Schulich School of Business - York University

MBA, Strategy, Marketing and Finance

SKILLS

Market AccessOncologyUrologyMedical DevicesBiotechnologyPharmaceutical IndustryGastroenterologyProduct LaunchSales EffectivenessPharmaceutical SalesDermatologyRheumatologyDiabetesCardiologyMarketing StrategyNeurology

ABOUT STEVE SMYTH

Business Unit Director, Multiple Myeloma, Janssen Canada, Johnson and Jonhson

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Steve Smyth — Business Unit Director, Multiple Myeloma at Johnson & Johnson Innovative Medicine in Barrie, ON, CA | Unifers